Company

Intech Biopharm Corp

Headquarters: Taipei, Taiwan

Employees: 89

TWSE: 6461 +0.37%

Market Cap

TW$4.23 Billion

TWD as of July 1, 2024

US$129.8 Million

Market Cap History

Intech Biopharm Corp market capitalization over time

Evolution of Intech Biopharm Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Intech Biopharm Corp

Detailed Description

Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform to treat asthma and chronic pulmonary obstructive disease; and dry powder inhaler. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation is headquartered in Taipei, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Intech Biopharm Corp has the following listings and related stock indices.


Stock: TWSE: 6461 wb_incandescent

Details

Headquarters:

No. 36, Ruiguang Road

3rd Floor Lane 358 Neihu District

Taipei, 114

Taiwan

Phone: 886 2 7721 8877

Fax: 886 2 7721 8800